tolazoline has been researched along with Developmental Disabilities in 2 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, RS | 1 |
Stevenson, DK | 1 |
Malachowski, N | 1 |
Ariagno, RL | 1 |
Johnson, JD | 1 |
Sunshine, P | 1 |
Andrews, AF | 1 |
Nixon, CA | 1 |
Cilley, RE | 1 |
Roloff, DW | 1 |
Bartlett, RH | 1 |
2 other studies available for tolazoline and Developmental Disabilities
Article | Year |
---|---|
Late morbidity among survivors of respiratory failure treated with tolazoline.
Topics: Child, Preschool; Developmental Disabilities; Humans; Infant, Newborn; Respiratory Distress Syndrome | 1980 |
One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation.
Topics: Cerebral Hemorrhage; Developmental Disabilities; Electroencephalography; Extracorporeal Circulation; | 1986 |